NEI Research News

The standard treatment for amblyopia, a condition of poor vision in an otherwise healthy eye, is patching: covering a child’s better-seeing eye with a patch for two hours a day to improve vision in the weaker eye.

A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain.

Study estimates prevalence of vision disorders among preschool children in three ethnic groups, identifies risk factors

Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children

A National Eye Institute (NEI) study found that the prevalence of myopia, or nearsightedness, increased 66 percent in the United States between 1971-1972 and 1999-2004.

Three young adults with an inherited form of blindness showed evidence of improved day and night vision following a specialized gene transfer procedure in a phase 1 clinical trial funded by the National Eye Institute (NEI), part of the NIH.

Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy.

Scientists have found a more effective treatment for a common childhood eye muscle coordination problem called convergence insufficiency (CI).

The National Eye Institute (NEI) of the National Institutes of Health (NIH) is supporting a phase I clinical trial to assess the safety of gene transfer in treating people with a form of Leber congenital amaurosis (LCA).

Omega-3 polyunsaturated fatty acids protect against the development and progression of retinopathy, a deterioration of the retina, in mice. This is the major finding of a study that appears in the July 2007 issue of the journal Nature Medicine.